Spero Therapeutics ROA 2024

Spero Therapeutics Aktienanalyse

What does Spero Therapeutics do?

Spero Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of serious infections. The company was founded in 2013 and is based in Cambridge, Massachusetts. Spero Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Spero Therapeutics's Return on Assets (ROA)

Spero Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Spero Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Spero Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Spero Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Spero Therapeutics Stock

What is the Return on Assets (ROA) of Spero Therapeutics this year?

The Return on Assets (ROA) of Spero Therapeutics is 0.13 undefined this year.

What was the ROA of Spero Therapeutics compared to the previous year?

The ROA of Spero Therapeutics has increased by -133.62% compared to the previous year.

What consequences do high ROA have for investors of Spero Therapeutics?

A high ROA is advantageous for investors of Spero Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Spero Therapeutics?

A low ROA can be unfavorable for investors of Spero Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Spero Therapeutics affect the company?

An increase in ROA of Spero Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Spero Therapeutics impact the company?

A reduction in the ROA of Spero Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Spero Therapeutics?

Some factors that can influence the ROA of Spero Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Spero Therapeutics important for investors?

The ROA of Spero Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Spero Therapeutics take to improve ROA?

To improve ROA, Spero Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Spero Therapeutics pay?

Over the past 12 months, Spero Therapeutics paid a dividend of 0.05 USD . This corresponds to a dividend yield of about 3.38 %. For the coming 12 months, Spero Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Spero Therapeutics?

The current dividend yield of Spero Therapeutics is 3.38 %.

When does Spero Therapeutics pay dividends?

Spero Therapeutics pays a quarterly dividend. This is distributed in the months of April, April, July, October.

How secure is the dividend of Spero Therapeutics?

Spero Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Spero Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Spero Therapeutics located?

Spero Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Spero Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Spero Therapeutics from 10/7/2015 amounting to 0.015 USD, you needed to have the stock in your portfolio before the ex-date on 9/16/2015.

When did Spero Therapeutics pay the last dividend?

The last dividend was paid out on 10/7/2015.

What was the dividend of Spero Therapeutics in the year 2023?

In the year 2023, Spero Therapeutics distributed 0 USD as dividends.

In which currency does Spero Therapeutics pay out the dividend?

The dividends of Spero Therapeutics are distributed in USD.